Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether exemestane plus everolimus are effective in
the treatment of patients who have achieved disease stabilization after induction
chemotherapy for hormone-receptor positive metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Organisation for Oncology and Translational Research